BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 11, Issue 5
This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (4875)
All Articles published online
The chart showing PDF series, HTML series, Tables (1-4) series.
Item 
Count 
PDF392
HTML4177
Tables (1-4)306
 Sum=4875
Feb 7, 2005 (publication date) through Mar 10, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Gazouli M, Mantzaris G, Kotsinas A, Zacharatos P, Papalambros E, Archimandritis A, Ikonomopoulos J, Gorgoulis VG. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J Gastroenterol 2005; 11(5): 681-685 [PMID: 15655821 DOI: 10.3748/wjg.v11.i5.681]
URL: https://www.wjgnet.com/1007-9327/full/v11/i5/681.htm
Number Citing Articles
1
Seth Rakoff-Nahoum, Liming Hao, Ruslan Medzhitov. Role of Toll-like Receptors in Spontaneous Commensal-Dependent Colitis. Immunity 2006; 25(2): 319 doi: 10.1016/j.immuni.2006.06.010
2
Nikolaos Kamperidis, Vasileios Kamperidis, Thomas Zegkos, Ioanna Kostourou, Olga Nikolaidou, Naila Arebi, Haralambos Karvounis. Atherosclerosis and Inflammatory Bowel Disease—Shared Pathogenesis and Implications for Treatment. Angiology 2021; 72(4): 303 doi: 10.1177/0003319720974552
3
Dulciene Maria Magalhães Queiroz, Adriana Gonçalves Oliveira, Ivan Euclides Borges Saraiva, Gifone Aguiar Rocha, Andreia Maria Camargos Rocha, Maria das Graças Pimenta Sanna, Juliana Becattini Guerra, Renato Dani, Maria de Lourdes Abreu Ferrari, Lúcia Porto Fonseca Castro. Immune Response and Gene Polymorphism Profiles in Crohnʼs Disease and Ulcerative Colitis. Inflammatory Bowel Diseases 2009; 15(3): 353 doi: 10.1002/ibd.20757
4
I. Hama, I. Ratbi, S. Reggoug, F. Elkerch, G. Kharrasse, I. Errabih, H. Ouazzani, A. Sefiani. Non-association of Crohn's disease with NOD2 gene variants in Moroccan patients. Gene 2012; 499(1): 121 doi: 10.1016/j.gene.2011.12.045
5
Michael Scharl, Gerhard Rogler. Microbial Sensing by the Intestinal Epithelium in the Pathogenesis of Inflammatory Bowel Disease. International Journal of Inflammation 2010; 2010: 1 doi: 10.4061/2010/671258
6
Lilla Lakner, Veronika Csöngei, Patrícia Sarlós, Luca Járomi, Enikő Sáfrány, Márta Varga, Péter Orosz, Lili Magyari, Judit Bene, Pál Miheller, Zsolt Tulassay, Béla Melegh. IGR2096a_1 T and IGR2198a_1 C alleles on IBD5 locus of chromosome 5q31 region confer risk for Crohn’s disease in Hungarian patients. International Journal of Colorectal Disease 2009; 24(5): 503 doi: 10.1007/s00384-009-0670-x
7
Alejandra Claudia Cherñavsky, María Carolina Páez, Natalia Periolo, Paula Correa, Laura Guillén, Sonia Isabel Niveloni, Eduardo Mauriño, Julio César Bai, Juan-Manuel Anaya. The simultaneous presence of IL-1B and TNFA two-positions risk haplotypes enhances the susceptibility for celiac disease. Cytokine 2008; 42(1): 48 doi: 10.1016/j.cyto.2008.01.015
8
Nader Bagheri, Fatemeh Azadegan-Dehkordi, Ghorbanali Rahimian, Morteza Hashemzadeh-Chaleshtori, Mahmoud Rafieian-Kopaei, Soleyman Kheiri, Abolfazl Gholipour, Hedayatollah Shirzad. Altered Th17 Cytokine Expression inHelicobacter pyloriPatients with TLR4 (D299G) Polymorphism. Immunological Investigations 2016; 45(2): 161 doi: 10.3109/08820139.2015.1122615
9
Tamas Jilling, Dyan Simon, Jing Lu, Fan Jing Meng, Dan Li, Robert Schy, Richard B. Thomson, Antoine Soliman, Moshe Arditi, Michael S. Caplan. The Roles of Bacteria and TLR4 in Rat and Murine Models of Necrotizing Enterocolitis. The Journal of Immunology 2006; 177(5): 3273 doi: 10.4049/jimmunol.177.5.3273
10
Marta Rusmini, Silvia Federici, Francesco Caroli, Alice Grossi, Maurizia Baldi, Laura Obici, Antonella Insalaco, Alberto Tommasini, Roberta Caorsi, Eleonora Gallo, Alma Nunzia Olivieri, AngeloValerio Marzano, Domenico Coviello, Roberto Ravazzolo, Alberto Martini, Marco Gattorno, Isabella Ceccherini. Next-generation sequencing and its initial applications for molecular diagnosis of systemic auto-inflammatory diseases. Annals of the Rheumatic Diseases 2016; 75(8): 1550 doi: 10.1136/annrheumdis-2015-207701
11
Zvi G. Fridlender, Asaf Schwartz, Martin Kohan, Gail Amir, Mendel Glazer, Neville Berkman. Association between CD14 gene polymorphisms and disease phenotype in sarcoidosis. Respiratory Medicine 2010; 104(9): 1336 doi: 10.1016/j.rmed.2010.03.029
12
E. Ann Misch, Thomas R. Hawn. Toll-like receptor polymorphisms and susceptibility to human disease. Clinical Science 2008; 114(5): 347 doi: 10.1042/CS20070214
13
Marie Pierik, Sofie Joossens, Kristel Van Steen, Nele Van Schuerbeek, Robert Vlietinck, Paul Rutgeerts, Severine Vermeire. Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflammatory Bowel Diseases 2006; 12(1): 1 doi: 10.1097/01.MIB.0000195389.11645.ab
14
Lissy de Ridder, Rinse K. Weersma, Gerard Dijkstra, Gerrit van der Steege, Marc A. Benninga, Ilja M. Nolte, Jan A.J. M. Taminiau, Daniël W. Hommes, Pieter C. F. Stokkers. Genetic susceptibility has a more important role in pediatric-onset Crohnʼs disease than in adult-onset Crohnʼs disease. Inflammatory Bowel Diseases 2007; 13(9): 1083 doi: 10.1002/ibd.20171
15
M. Kidd, B. I. Gustafsson, I. Drozdov, I. M. Modlin. IL1β‐ and LPS‐induced serotonin secretion is increased in EC cells derived from Crohn’s disease. Neurogastroenterology & Motility 2009; 21(4): 439 doi: 10.1111/j.1365-2982.2008.01210.x
16
Alexandra M. Vlk, Daniel Prantner, Kari Ann Shirey, Darren J. Perkins, Marguerite S. Buzza, Vivek Thumbigere-Math, Achsah D. Keegan, Stefanie N. Vogel, Alejandro Aballay. M2a macrophages facilitate resolution of chemically-induced colitis in TLR4-SNP mice. mBio 2023; 14(5) doi: 10.1128/mbio.01208-23
17
Chao Xuan, Bei-Bei Zhang, Tao Yang, Kai-Feng Deng, Ming Li, Rui-Juan Tian. Association between OCTN1/2 gene polymorphisms (1672C-T, 207G-C) and susceptibility of Crohn's disease: a meta-analysis. International Journal of Colorectal Disease 2012; 27(1): 11 doi: 10.1007/s00384-011-1265-x
18
Peter Laszlo Lakatos, Erika Hitre, Ferenc Szalay, Kerstin Zinober, Peter Fuszek, Laszlo Lakatos, Simon Fischer, Janos Osztovits, Orsolya Gemela, Gabor Veres, Janos Papp, Peter Ferenci. Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients. BMC Cancer 2007; 7(1) doi: 10.1186/1471-2407-7-54
19
B. Vucelic, S. Cukovic-Cavka. IBD 2007 — Achievements in Research and Clinical Practice. Falk Symposium 2008; 159: 30 doi: 10.1007/978-1-4020-6987-1_3
20
Mei Yuan, Jian Xia, Lin Ma, Bo Xiao, Qidong Yang. Lack of the Toll-Like Receptor 4 Gene Polymorphisms Asp299Gly and Thr399ile in a Chinese Population. International Journal of Neuroscience 2010; 120(6): 415 doi: 10.3109/00207451003778736
21
Peter Laszlo Lakatos, Lajos Sandor Kiss, Karoly Palatka, Istvan Altorjay, Peter Antal-Szalmas, Eszter Palyu, Miklos Udvardy, Tamas Molnar, Klaudia Farkas, Gabor Veres, Jolan Harsfalvi, Janos Papp, Maria Papp. Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohnʼs disease. Inflammatory Bowel Diseases 2011; 17(3): 767 doi: 10.1002/ibd.21402
22
Maria T. Abreu, Masayuki Fukata, Keith Breglio. Inflammatory Bowel Disease. 2010; : 64 doi: 10.1002/9781444318418.ch7
23
Colin Noble, Elaine Nimmo, Daniel Gaya, Richard K Russell, Jack Satsangi. Novel susceptibility genes in inflammatory bowel disease. World Journal of Gastroenterology 2006; 12(13): 1991-1999 doi: 10.3748/wjg.v12.i13.1991
24
Shu-Chen Wei, Yen-Hsuan Ni, Hwai-I. Yang, Yi-Nin Su, Ming-Chu Chang, Yu-Ting Chang, Ming-Jium Shieh, Cheng-Yi Wang, Jau-Min Wong. A hospital-based study of clinical and genetic features of Crohn’s disease. Journal of the Formosan Medical Association 2011; 110(9): 600 doi: 10.1016/j.jfma.2011.07.009
25
C. Maldonado‐Bernal, A. Trejo‐de la O, M. E. Sánchez‐Contreras, N. Wacher‐Rodarte, J. Torres, M. Cruz. Low frequency of Toll‐like receptors 2 and 4 gene polymorphisms in Mexican patients and their association with Type 2 diabetes. International Journal of Immunogenetics 2011; 38(6): 519 doi: 10.1111/j.1744-313X.2011.01035.x
26
Qin Wu, Xiaomeng Xu, Jianan Ren, Song Liu, Xuelian Liao, Xiuwen Wu, Dong Hu, Gefei Wang, Guosheng Gu, Yan Kang, Jieshou Li. Association between the -159C/T polymorphism in the promoter region of the CD14 gene and sepsis: a meta-analysis. BMC Anesthesiology 2017; 17(1) doi: 10.1186/s12871-017-0303-9
27
Senka Dobric, Dragan Popovic, Milos Nikolic, Sladjana Andrejevic, Milan Spuran, Branka Bonaci-Nikolic. Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis. Clinical Chemistry and Laboratory Medicine 2012; 50(3) doi: 10.1515/cclm.2011.797
28
Monika Buraczynska, Iwona Baranowicz-Gaszczyk, Jerzy Tarach, Andrzej Ksiazek. Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes. Human Immunology 2009; 70(2): 121 doi: 10.1016/j.humimm.2008.12.003
29
Claudia Huebner, Ivonne Petermann, Wen Jiun Lam, Andrew N. Shelling, Lynnette R. Ferguson. Characterization of single-nucleotide polymorphisms relevant to inflammatory bowel disease in commonly used gastrointestinal cell lines. Inflammatory Bowel Diseases 2010; 16(2): 282 doi: 10.1002/ibd.21043
30
Klaas van der Linde, Patrick P.C. Boor, Jeanine J. Houwing-Duistermaat, Bart J.A. Crusius, Paul J.H. Wilson, Ernst J. Kuipers, Felix W.M. de Rooij. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies. European Journal of Gastroenterology & Hepatology 2007; 19(6): 449 doi: 10.1097/01.meg.0000236887.44214.6a
31
Kristen O. Arseneau, Hiroshi Tamagawa, Theresa T. Pizarro, Fabio Cominelli. Innate and adaptive immune responses related to IBD pathogenesis. Current Gastroenterology Reports 2007; 9(6): 508 doi: 10.1007/s11894-007-0067-3
32
M Hedl, C Abraham. Negative regulation of human mononuclear phagocyte function. Mucosal Immunology 2013; 6(2): 205 doi: 10.1038/mi.2012.139
33
Christian U Riedel, Francis Foata, David Philippe, Oskar Adolfsson, Bernhard J Eikmanns, Stephanie Blum. Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-κB activation. World Journal of Gastroenterology 2006; 12(23): 3729-3735 doi: 10.3748/wjg.v12.i23.3729
34
Rieko Okada, Koji Suzuki, Yoshinori Ito, Kazuko Nishio, Yoshiko Ishida, Sayo Kawai, Yasuyuki Goto, Mariko Naito, Kenji Wakai, Nobuyuki Hamajima. Association between Decreased Kidney Function and Endotoxin ReceptorCD14C-159T Polymorphism among Japanese Health Check-up Examinees. Renal Failure 2007; 29(8): 967 doi: 10.1080/08860220701641686
35
M Fukata, M T Abreu. Role of Toll-like receptors in gastrointestinal malignancies. Oncogene 2008; 27(2): 234 doi: 10.1038/sj.onc.1210908
36
S Pabst, G Baumgarten, A Stremmel, M Lennarz, P Knüfermann, A Gillissen, H Vetter, C Grohé. Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis. Clinical and Experimental Immunology 2006; 143(3): 420 doi: 10.1111/j.1365-2249.2006.03008.x
37
Eniko Safrany, Melinda Szabo, Marta Szell, Lajos Kemeny, Katalin Sumegi, Bela I. Melegh, Lili Magyari, Petra Matyas, Maria Figler, Agnes Weber, Zsolt Tulassay, Bela Melegh. Difference of interleukin-23 receptor gene haplotype variants in ulcerative colitis compared to Crohn’s disease and psoriasis. Inflammation Research 2013; 62(2): 195 doi: 10.1007/s00011-012-0566-z
38
Peter Laszlo Lakatos, Simon Fischer, Laszlo Lakatos, Istvan Gal, Janos Papp. Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: Pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take “toll”. World Journal of Gastroenterology 2006; 12(12): 1829-1841 doi: 10.3748/wjg.v12.i12.1829
39
Pei Yee Ma, Jing En Tan, Edd Wyn Hee, Dylan Wang Xi Yong, Yi Shuan Heng, Wei Xiang Low, Xun Hui Wu, Christy Cletus, Dinesh Kumar Chellappan, Kyan Aung, Chean Yeah Yong, Yun Khoon Liew. Human Genetic Variation Influences Enteric Fever Progression. Cells 2021; 10(2): 345 doi: 10.3390/cells10020345
40
Katja Repnik, Uroš Potočnik. Haplotype in the IBD5 region is associated with refractory Crohn’s disease in Slovenian patients and modulates expression of the SLC22A5 gene. Journal of Gastroenterology 2011; 46(9): 1081 doi: 10.1007/s00535-011-0426-6
41
Séverine Vermeire, Dermot P. McGovern, Gert Van Assche, Paul Rutgeerts. Inflammatory Bowel Disease. 2010; : 16 doi: 10.1002/9781444318418.ch4
42
Corinna Hermann. Review: Variability of host—pathogen interaction. Journal of Endotoxin Research 2007; 13(4): 199 doi: 10.1177/0968051907082605
43
Philippe Goyette, Catherine Labbé, Truc T. Trinh, Ramnik J. Xavier, John D. Rioux. Molecular pathogenesis of inflammatory bowel disease: Genotypes, phenotypes and personalized medicine. Annals of Medicine 2007; 39(3): 177 doi: 10.1080/07853890701197615
44
Nahla Azzam, Howaida Nounou, Othman Alharbi, Abedulrahman Aljebreen, Manal Shalaby. CARD15/NOD2, CD14 and Toll-like 4 Receptor Gene Polymorphisms in Saudi Patients with Crohn’s Disease. International Journal of Molecular Sciences 2012; 13(4): 4268 doi: 10.3390/ijms13044268
45
K. Triantafyllou, A. Kourikou, M. Gazouli, G. P. Karamanolis, G. D. Dimitriadis. Functional dyspepsia susceptibility is related to CD14,GNB3,MIF, and TRPV1 gene polymorphisms in the Greek population. Neurogastroenterology & Motility 2017; 29(1) doi: 10.1111/nmo.12913
46
Michael Economou, Georgios Pappas. New global map of Crohnʼs disease: Genetic, environmental, and socioeconomic correlations. Inflammatory Bowel Diseases 2008; 14(5): 709 doi: 10.1002/ibd.20352
47
Pedro Pimentel-Nunes, João Bruno Soares, Roberto Roncon-Albuquerque Jr, Mário Dinis-Ribeiro, Adelino F Leite-Moreira. Toll-like receptors as therapeutic targets in gastrointestinal diseases. Expert Opinion on Therapeutic Targets 2010; 14(4): 347 doi: 10.1517/14728221003642027
48
Kathrin S Michelsen, Moshe Arditi. Toll-like receptors and innate immunity in gut homeostasis and pathology. Current Opinion in Hematology 2007; 14(1): 48 doi: 10.1097/00062752-200701000-00010
49
Ivonne Petermann, Claudia Huebner, Brian L. Browning, Richard B. Gearry, Murray L. Barclay, Martin Kennedy, Rebecca Roberts, Andrew N. Shelling, Martin Philpott, Dug Yeo Han, Lynnette R. Ferguson. Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort. Human Immunology 2009; 70(6): 440 doi: 10.1016/j.humimm.2009.03.002
50
Fangyu Wang, Tomomitsu Tahara, Tomiyasu Arisawa, Tomoyuki Shibata, Masakatsu Nakamura, Hiroshi Fujita, Masami Iwata, Yoshio Kamiya, Mitsuo Nagasaka, Kazuya Takahama, Makoto Watanabe, Ichiro Hirata, Hiroshi Nakano. Genetic polymorphisms of CD14 and Toll‐like receptor‐2 (TLR2) in patients with ulcerative colitis. Journal of Gastroenterology and Hepatology 2007; 22(6): 925 doi: 10.1111/j.1440-1746.2007.04909.x
51
S. VERMEIRE. Review article: genetic susceptibility and application of genetic testing in clinical management of inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2006; 24(s3): 2 doi: 10.1111/j.1365-2036.2006.03052.x
52
Georgia E. Hume, Elizabeth V. Fowler, James Doecke, Lisa A. Simms, Ning Huang, Orazio Palmieri, Lyn R. Griffiths, Timothy H.J. Florin, Vito Annese, Graham L. Radford-Smith. Novel NOD2 haplotype strengthens the association between TLR4 Asp299gly and Crohnʼs disease in an Australian population. Inflammatory Bowel Diseases 2008; 14(5): 585 doi: 10.1002/ibd.20362
53
Eun Jung Kim, Woo Chul Chung, Kang-Moon Lee, Chang Nyol Paik, Sung Hoon Jung, Bo In Lee, Hiun Suk Chae, Kyu Yong Choi. Association Between Toll-Like Receptors/CD14 Gene Polymorphisms and Inflammatory Bowel Disease in Korean Population. Journal of Korean Medical Science 2012; 27(1): 72 doi: 10.3346/jkms.2012.27.1.72
54
R. K. WEERSMA, H. M. VAN DULLEMEN, G. VAN DER STEEGE, I. M. NOLTE, J. H. KLEIBEUKER, G. DIJKSTRA. Review article: inflammatory bowel disease and genetics. Alimentary Pharmacology & Therapeutics 2007; 26(s2): 57 doi: 10.1111/j.1365-2036.2007.03476.x
55
Ioannis S. Pateras, Sophia Havaki, Xenia Nikitopoulou, Konstantinos Vougas, Paul A. Townsend, Michalis I. Panayiotidis, Alexandros G. Georgakilas, Vassilis G. Gorgoulis. The DNA damage response and immune signaling alliance: Is it good or bad? Nature decides when and where. Pharmacology & Therapeutics 2015; 154: 36 doi: 10.1016/j.pharmthera.2015.06.011
56
Johan Van Limbergen, Richard K. Russell, Elaine R. Nimmo, Jack Satsangi. The Genetics of Inflammatory Bowel Disease. The American Journal of Gastroenterology 2007; 102(12): 2820 doi: 10.1111/j.1572-0241.2007.01527.x
57
C. D. Packey, R. B. Sartor. Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases. Journal of Internal Medicine 2008; 263(6): 597 doi: 10.1111/j.1365-2796.2008.01962.x
58
Vasiliki Nezi, Melanie Deutsch, Maria Gazouli, Alexandra Alexopoulou, Thomas Paparrigopoulos, Ioannis A. Liappas, Spyros P. Dourakis. Polymorphisms of the CD14 Genes are Associated with Susceptibility to Alcoholic Liver Disease in Greek Patients. Alcoholism: Clinical and Experimental Research 2013; 37(2): 244 doi: 10.1111/j.1530-0277.2012.01925.x
59
Brian L. Browning, Claudia Huebner, Ivonne Petermann, Pieter Demmers, Alan McCulloch, Richard B. Gearry, Murray L. Barclay, Andrew N. Shelling, Lynnette R. Ferguson. Association of DLG5 variants with inflammatory bowel disease in the New Zealand caucasian population and meta-analysis of the DLG5 R30Q variant. Inflammatory Bowel Diseases 2007; 13(9): 1069 doi: 10.1002/ibd.20157
60
Johan Van Limbergen, Richard K. Russell, Elaine R. Nimmo, Gwo-Tzer Ho, Ian D. Arnott, David C. Wilson, Jack Satsangi. Genetics of the innate immune response in inflammatory bowel disease. Inflammatory Bowel Diseases 2007; 13(3): 338 doi: 10.1002/ibd.20096
61
Ulrike Strauch, Jürgen Schölmerich. Emerging drugs to treat Crohn's disease. Expert Opinion on Emerging Drugs 2010; 15(2): 309 doi: 10.1517/14728214.2010.480972
62
Jennifer A. Greenhall, Matthew A. Zapala, Mario Cáceres, Ondrej Libiger, Carrolee Barlow, Nicholas J. Schork, David J. Lockhart. Detecting genetic variation in microarray expression data. Genome Research 2007; 17(8): 1228 doi: 10.1101/gr.6307307
63
Brian L. Browning, Claudia Huebner, Ivonne Petermann, Richard B Gearry, Murray L. Barclay, Andrew N. Shelling, Lynnette R. Ferguson. Has Toll-Like Receptor 4 Been Prematurely Dismissed as an Inflammatory Bowel Disease Gene? Association Study Combined With Meta-Analysis Shows Strong Evidence for Association. The American Journal of Gastroenterology 2007; 102(11): 2504 doi: 10.1111/j.1572-0241.2007.01463.x
64
Ali Tüzün İnce, Özden Hatırnaz, Oya Övünç, Uğur Özbek. 1007fs, G908R, R702W Mutations and P268S, IVS8+158 Polymorphisms of the CARD15 Gene in Turkish Inflammatory Bowel Disease Patients and Their Relationship with Disease-Related Surgery. Digestive Diseases and Sciences 2008; 53(6): 1683 doi: 10.1007/s10620-007-0054-4
65
Naresh Kumar Meena, Vineet Ahuja, Kusumlata Meena, Jaishree Paul, Matthaios Speletas. Association of TLR5 Gene Polymorphisms in Ulcerative Colitis Patients of North India and Their Role in Cytokine Homeostasis. PLOS ONE 2015; 10(3): e0120697 doi: 10.1371/journal.pone.0120697
66
Jorge Domínguez-Andrés, Mihai G. Netea. Impact of Historic Migrations and Evolutionary Processes on Human Immunity. Trends in Immunology 2019; 40(12): 1105 doi: 10.1016/j.it.2019.10.001
67
Meiqian Weng, W. Allan Walker. Bacterial colonization, probiotics, and clinical disease. The Journal of Pediatrics 2006; 149(5): S107 doi: 10.1016/j.jpeds.2006.06.061
68
Yu-Feng Qing, Quan-Bo Zhang, Jing-Guo Zhou. Innate immunity functional gene polymorphisms and gout susceptibility. Gene 2013; 524(2): 412 doi: 10.1016/j.gene.2013.04.039
69
Anton G. Kutikhin, Arseniy E. Yuzhalin. Genomics of Pattern Recognition Receptors. 2013; : 123 doi: 10.1007/978-3-0348-0688-6_7
70
Alba Martinez-Chamorro, Antonia Moreno, María Gómez-García, María José Cabello, Javier Martin, Miguel Ángel Lopez-Nevot. Epistatic interaction between TLR4 and NOD2 in patients with Crohn’s Disease: relation with risk and phenotype in a Spanish cohort. Immunobiology 2016; 221(9): 927 doi: 10.1016/j.imbio.2016.05.015
71
Lilia Zouiten-Mekki, Maher Kharrat, Sami Karoui, Mariem Serghimi, Monia Fekih, Samira Matri, Lamia Kallel, Jalel Boubaker, Azza Filali, Habiba Chaabouni. Tolllike receptor 4 (TLR4) polymorphisms in Tunisian patients with Crohn's disease: genotype-phenotype correlation. BMC Gastroenterology 2009; 9(1) doi: 10.1186/1471-230X-9-62
72
Paulo Freire, Ricardo Cardoso, Pedro Figueiredo, Maria M. Donato, Manuela Ferreira, Sofia Mendes, Ana Margarida Ferreira, Helena Vasconcelos, Francisco Portela, Carlos Sofia. NOD2 gene mutations in ulcerative colitis: useless or misunderstood?. International Journal of Colorectal Disease 2014; 29(6): 653 doi: 10.1007/s00384-014-1850-x
73
Shane M. Devlin, Huiying Yang, Andrew Ippoliti, Kent D. Taylor, Carol J. Landers, Xiaowen Su, Maria T. Abreu, Konstantinos A. Papadakis, Eric A. Vasiliauskas, Gil Y. Melmed, Phillip R. Fleshner, Ling Mei, Jerome I. Rotter, Stephan R. Targan. NOD2 Variants and Antibody Response to Microbial Antigens in Crohn’s Disease Patients and Their Unaffected Relatives. Gastroenterology 2007; 132(2): 576 doi: 10.1053/j.gastro.2006.11.013
74
Jean-Pierre Hugot, Isabelle Zaccaria, Juleen Cavanaugh, Huiying Yang, Sverine Vermeire, Maarit Lappalainen, Stefan Schreiber, Vito Annese, Derek P Jewell, Elizabeth V Fowler, Steven R Brant, Mark S Silverberg, Judy Cho, John D Rioux, Jack Satsangi, Miles Parkes. Prevalence of CARD15/NOD2 Mutations in Caucasian Healthy People. The American Journal of Gastroenterology 2007; 102(6): 1259 doi: 10.1111/j.1572-0241.2007.01149.x
75
Jiwon Hong, Euphemia Leung, Alan G Fraser, Tony R Merriman, Prakash Vishnu, Geoffrey W Krissansen. TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort. Journal of Gastroenterology and Hepatology 2007; 22(11): 1760 doi: 10.1111/j.1440-1746.2006.04727.x
76
Shunji Ishihara, M. M. Aziz, Takafumi Yuki, Hideaki Kazumori, Yoshikazu Kinoshita. Inflammatory bowel disease: review from the aspect of genetics. Journal of Gastroenterology 2009; 44(11): 1097 doi: 10.1007/s00535-009-0141-8
77
Maria Gazouli, Gerassimos Mantzaris, Athanassios J Archimandritis, George Nasioulas, Nicholas P Anagnou. Single nucleotide polymorphisms of <i>OCTN1</i>, <i>OCTN2</i>, and <i>DLG5</i> genes in Greek patients with Crohn&rsquo;s disease. World Journal of Gastroenterology 2005; 11(47): 7525-7530 doi: 10.3748/wjg.v11.i47.7525
78
Spyros Vrakas, Konstantinos C. Mountzouris, George Michalopoulos, George Karamanolis, George Papatheodoridis, Charalampos Tzathas, Maria Gazouli, Leonardo A. Sechi. Intestinal Bacteria Composition and Translocation of Bacteria in Inflammatory Bowel Disease. PLOS ONE 2017; 12(1): e0170034 doi: 10.1371/journal.pone.0170034
79
Nastaran Kordjazy, Arvin Haj-Mirzaian, Arya Haj-Mirzaian, Mohammad Mojtaba Rohani, Erwin W. Gelfand, Nima Rezaei, Amir Hossein Abdolghaffari. Role of toll-like receptors in inflammatory bowel disease. Pharmacological Research 2018; 129: 204 doi: 10.1016/j.phrs.2017.11.017
80
Yang Cheng, Yun Zhu, Xiuping Huang, Wei Zhang, Zelong Han, Side Liu, David L Boone. Association between TLR2 and TLR4 Gene Polymorphisms and the Susceptibility to Inflammatory Bowel Disease: A Meta-Analysis. PLOS ONE 2015; 10(5): e0126803 doi: 10.1371/journal.pone.0126803
81
Zhiquan Fu, Yanting Shen, Liubing Lin, Yirong Chen, Yong Li, Renye Que. Association between Toll-Like Receptor 4 T399I Gene Polymorphism and the Susceptibility to Crohn’s Disease: A Meta-Analysis of Case-Control Studies. Digestion 2018; 97(3): 250 doi: 10.1159/000485027
82
Brian M. Necela, Weidong Su, E. Aubrey Thompson. Toll‐like receptor 4 mediates cross‐talk between peroxisome proliferator‐activated receptor γ and nuclear factor‐κB in macrophages. Immunology 2008; 125(3): 344 doi: 10.1111/j.1365-2567.2008.02849.x
83
XINXIN ZHAO, SHAN KANG, LINGLING LIU, DONGFENG ZHANG. Correlation of Asp299Gly and Thr399Ile polymorphisms in toll-like receptor 4 gene with digestive cancer risk: A meta-analysis. Biomedical Reports 2013; 1(2): 294 doi: 10.3892/br.2012.32
84
Suprabhat Mukherjee, Sahel Huda, Santi P. Sinha Babu. Toll‐like receptor polymorphism in host immune response to infectious diseases: A review. Scandinavian Journal of Immunology 2019; 90(1) doi: 10.1111/sji.12771
85
Jing Wang, Wen Cao, Tao Ji, Minjie Zhao, Tao Liu, Junhao Wu, Fengqin Feng, Aicun Zhou, Xin Peng. Gut microbiota and transcriptome profiling revealed the protective effect of aqueous extract of Tetrastigma hemsleyanum leaves on ulcerative colitis in mice. Current Research in Food Science 2023; 6: 100426 doi: 10.1016/j.crfs.2022.100426
86
Anton G. Kutikhin. Role of NOD1/CARD4 and NOD2/CARD15 gene polymorphisms in cancer etiology. Human Immunology 2011; 72(10): 955 doi: 10.1016/j.humimm.2011.06.003
87
Nader Bagheri, Fatemeh Azadegan-Dehkordi, Hosein Sanei, Afshin Taghikhani, Ghorbanali Rahimian, Loghman Salimzadeh, Morteza Hashemzadeh-Chaleshtori, Mahmoud Rafieian-kopaei, Maryam Shirzad, Hedayatollah Shirzad. Associations of a TLR4 single-nucleotide polymorphism with H. pylori associated gastric diseases in iranian patients. Clinics and Research in Hepatology and Gastroenterology 2014; 38(3): 366 doi: 10.1016/j.clinre.2013.12.004
88
Ramón A. Juste, Natalia Elguezabal, Andrés Pavón, Joseba M. Garrido, Mariví Geijo, Iker Sevilla, José L. Cabriada, Angel Tejada, Francisco García-Campos, Roberto Casado, Itziar Ochotorena, Ander Izeta. Association between Mycobacterium avium subsp. paratuberculosis DNA in blood and cellular and humoral immune response in inflammatory bowel disease patients and controls. International Journal of Infectious Diseases 2009; 13(2): 247 doi: 10.1016/j.ijid.2008.06.034
89
Kirankumar Baskaran, Srinivasan Pugazhendhi, Balakrishnan Ramakrishna. Toll-Like Receptor Gene Polymorphisms in Indian Patients with Inflammatory Bowel Disease. Gastroenterology, Hepatology and Endoscopy Practice 2021; 1(1): 22 doi: 10.4103/ghep.ghep_2_20
90
Maarit Lappalainen, Leena Halme, Ulla Turunen, Päivi Saavalainen, Elisabet Einarsdottir, Martti Färkkilä, Kimmo Kontula, Paulina Paavola-Sakki. Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population. Inflammatory Bowel Diseases 2008; 14(8): 1118 doi: 10.1002/ibd.20431
91
Alejandra Trejo-de la O, Javier Torres, Martha Pérez-Rodríguez, Margarita Camorlinga-Ponce, L Flores Luna, José M. Abdo-Francis, Eduardo Lazcano, Carmen Maldonado-Bernal. TLR4 single-nucleotide polymorphisms alter mucosal cytokine and chemokine patterns in Mexican patients with Helicobacter pylori-associated gastroduodenal diseases. Clinical Immunology 2008; 129(2): 333 doi: 10.1016/j.clim.2008.07.009
92
Alexia Gomart, Alexandre Vallée, Yves Lecarpentier. Necrotizing Enterocolitis: LPS/TLR4-Induced Crosstalk Between Canonical TGF-β/Wnt/β-Catenin Pathways and PPARγ. Frontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.713344
93
F Lanzarotto, A Akbar, S Ghosh. Does innate immune response defect underlie inflammatory bowel disease in the Asian population?. Postgraduate Medical Journal 2005; 81(958): 483 doi: 10.1136/pgmj.2005.036590
94
Ikuko Kato, Federico Canzian, Martyn Plummer, Silvia Franceschi, Leen-Jan van Doorn, Jorge Vivas, Gladys Lopez, Yanhui Lu, Lydie Gioia-Patricola, Richard K. Severson, Ann G. Schwartz, Nubia Muñoz. Polymorphisms in Genes Related to Bacterial Lipopolysaccharide/Peptidoglycan Signaling and Gastric Precancerous Lesions in a Population at High Risk for Gastric Cancer. Digestive Diseases and Sciences 2007; 52(1): 254 doi: 10.1007/s10620-006-9303-1
95
Nezha Senhaji, Brehima Diakité, Nadia Serbati, Younes Zaid, Wafaa Badre, Sellama Nadifi. Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms: New data and a meta-analysis. BMC Gastroenterology 2014; 14(1) doi: 10.1186/s12876-014-0206-x
96
P L De Jager, D Franchimont, A Waliszewska, A Bitton, A Cohen, D Langelier, J Belaiche, S Vermeire, L Farwell, A Goris, C Libioulle, N Jani, T Dassopoulos, G P Bromfield, B Dubois, J H Cho, S R Brant, R H Duerr, H Yang, J I Rotter, M S Silverberg, A H Steinhart, M J Daly, D K Podolsky, E Louis, D A Hafler, J D Rioux. The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes & Immunity 2007; 8(5): 387 doi: 10.1038/sj.gene.6364398
97
Yu Li, Yuanyuan Chen, Lili Jiang, Jingyu Zhang, Xuhui Tong, Dapeng Chen, Weidong Le. Intestinal Inflammation and Parkinson’s Disease. Aging and disease 2021; 12(8): 2052 doi: 10.14336/AD.2021.0418
98
Liekele E Oostenbrug, Joost P. H. Drenth, Dirk J de Jong, Ilja M Nolte, Elvira Oosterom, Hendrik M van Dullemen, Klaas van der Linde, Gerard J te Meerman, Gerrit van der Steege, Jan H Kleibeuker, Peter L. M. Jansen. Association Between Toll-like Receptor 4 and Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2005; 11(6): 567 doi: 10.1097/01.MIB.0000161305.81198.0f
99
Maike F. de Buhr, Hans J. Hedrich, Astrid M. Westendorf, Florian Obermeier, Claudia Hofmann, Nils H. Zschemisch, Jan Buer, Dirk Bumann, Sanna M. Goyert, Andre Bleich. Analysis of Cd14 as a genetic modifier of experimental inflammatory bowel disease (IBD) in mice. Inflammatory Bowel Diseases 2009; 15(12): 1824 doi: 10.1002/ibd.21030
100
Byong Duk Ye, Suk-Kyun Yang, Kyuyoung Song, Dong-Hoon Yang, Soon Man Yoon, Kyung Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Jin-Ho Kim. Association of Toll-Like Receptor Gene with Crohn's Disease in Koreans. The Korean Journal of Gastroenterology 2009; 54(6): 377 doi: 10.4166/kjg.2009.54.6.377
101
H. Peeters, S. Bogaert, D. Laukens, P. Rottiers, Filip De Keyser, A. Darfeuille‐Michaud, A.‐L. Glasser, D. Elewaut, M. De Vos. CARD15 variants determine a disturbed early response of monocytes to adherent‐invasive Escherichia coli strain LF82 in Crohn's disease. International Journal of Immunogenetics 2007; 34(3): 181 doi: 10.1111/j.1744-313X.2007.00670.x
102
Olusola Ojurongbe, Roland I Funwei, Tara J Snyder, Najihah Aziz, Yi Li, Catherine O. Falade, Bolaji N Thomas. Genetic Diversity of CD14 Promoter Gene Polymorphism (rs2569190) is Associated With Regulation of Malaria Parasitemia and Susceptibility to Plasmodium falciparum Infection. Infectious Diseases: Research and Treatment 2017; 10 doi: 10.1177/1178633617726781
103
Lynnette R. Ferguson, Andrew N. Shelling, Brian L. Browning, Claudia Huebner, Ivonne Petermann. Genes, diet and inflammatory bowel disease. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2007; 622(1-2): 70 doi: 10.1016/j.mrfmmm.2007.05.011
104
M. I. VILLASEÑOR‐CARDOSO, E. ORTEGA. Polymorphisms of innate immunity receptors in infection by parasites. Parasite Immunology 2011; 33(12): 643 doi: 10.1111/j.1365-3024.2011.01327.x
105
Evagelia Spanou, Polyxeni Kalisperati, Ioannis S. Pateras, Alexandros Papalampros, Alexandra Barbouti, Athanasios G. Tzioufas, Athanassios Kotsinas, Stavros Sougioultzis. Genetic Variability as a Regulator of TLR4 and NOD Signaling in Response to Bacterial Driven DNA Damage Response (DDR) and Inflammation: Focus on the Gastrointestinal (GI) Tract. Frontiers in Genetics 2017; 8 doi: 10.3389/fgene.2017.00065
106
Maria Gazouli, Nikolas Dovrolis, Andre Franke, George M. Spyrou, Leonardo A. Sechi, George Kolios. Differential genetic and functional background in inflammatory bowel disease phenotypes of a Greek population: a systems bioinformatics approach. Gut Pathogens 2019; 11(1) doi: 10.1186/s13099-019-0312-y
107
Lene Riis, Ida Vind, Severine Vermeire, Frank Wolters, Kostas Katsanos, Patrizia Politi, João Freitas, Ioannis A. Mouzas, Colm OʼMorain, Victor Ruiz-Ochoa, Selwyn Odes, Vibeke Binder, Pia Munkholm, Bjrn Moum, Reinhold Stockbrügger, Ebbe Langholz. The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients. Inflammatory Bowel Diseases 2007; 13(1): 24 doi: 10.1002/ibd.20047
108
Jian Wang, Xi Wang, Hong Yang, Dong Wu, Li Wang, Jiaming Qian. Contribution of the IBD5 locus to inflammatory bowel disease: a meta-analysis. Human Genetics 2011; 129(6): 597 doi: 10.1007/s00439-011-0952-6
109
Judy H Cho. Inflammatory bowel disease: Genetic and epidemiologic considerations. World Journal of Gastroenterology 2008; 14(3): 338-347 doi: 10.3748/wjg.14.338
110
Brooke N. Seamans, Summer L. Pellechio, Anna L. Capria, Smith E. Agyingi, Olanrewaju B. Morenikeji, Olusola Ojurongbe, Bolaji N. Thomas. Genetic diversity of CD14, CD28, CTLA-4 and ICOS gene promoter polymorphism in African and American sickle cell disease. Human Immunology 2019; 80(11): 930 doi: 10.1016/j.humimm.2019.08.005
111
N. Najmi, G. Kaur, S. K. Sharma, N. K. Mehra. Human Toll-like receptor 4 polymorphismsTLR4Asp299Gly and Thr399Ile influence susceptibility and severity of pulmonary tuberculosis in the Asian Indian population. Tissue Antigens 2010;  doi: 10.1111/j.1399-0039.2010.01481.x
112
Vito Annese, Anna Latiano, Orazio Palmieri, Angelo Andriulli. Dissecting genetic predisposition to inflammatory bowel disease: current progress and prospective application. Expert Review of Clinical Immunology 2007; 3(3): 287 doi: 10.1586/1744666X.3.3.287
113
Elena Urcelay, Fiona Blanco-Kelly, Virginia de las Heras, Emilio G. de la Concha, Rafael Arroyo, Alfonso Martínez. TLR4 haplotypes in multiple sclerosis: A case-control study in the Spanish population. Journal of Neuroimmunology 2007; 192(1-2): 215 doi: 10.1016/j.jneuroim.2007.10.001
114
Danial Jahantigh, Saeedeh Salimi, Roya Alavi-Naini, Abolfazl Emamdadi, Hamid Owaysee Osquee, Farzaneh Farajian Mashhadi, Josep Maria Gatell, Ekambar Kandimalla. Association between TLR4 and TLR9 Gene Polymorphisms with Development of Pulmonary Tuberculosis in Zahedan, Southeastern Iran. The Scientific World Journal 2013; 2013(1) doi: 10.1155/2013/534053
115
P. L. Lakatos. Pathogenesis and Clinical Practice in Gastroenterology. 2008; 160: 43 doi: 10.1007/978-1-4020-8767-7_6
116
Si Ming Man, Nadeem O. Kaakoush, Hazel M. Mitchell. The role of bacteria and pattern-recognition receptors in Crohn's disease. Nature Reviews Gastroenterology & Hepatology 2011; 8(3): 152 doi: 10.1038/nrgastro.2011.3
117
Z Liu, X Chen, X Wang, X Chen, C-H Song, Y Du, J Su, S A Yaseen, P-C Yang. Chemokine CXCL11 links microbial stimuli to intestinal inflammation. Clinical and Experimental Immunology 2011; 164(3): 396 doi: 10.1111/j.1365-2249.2011.04382.x
118
Jingwei Liu, Caiyun He, Qian Xu, Chengzhong Xing, Yuan Yuan, William B. Coleman. NOD2 Polymorphisms Associated with Cancer Risk: A Meta-Analysis. PLoS ONE 2014; 9(2): e89340 doi: 10.1371/journal.pone.0089340
119
Eun Jung Kim, Woo Chul Chung, Kang-Moon Lee, Chang Nyol Paik, Sung Hoon Jung, Bo In Lee, Hiun Suk Chae, Kyu Yong Choi. Association Between Toll-Like Receptors/CD14 Gene Polymorphisms and Inflammatory Bowel Disease in Korean Population. Journal of Korean Medical Science 2012; 27(1): 72 doi: 10.3346/jkms.2012.27.1.72
120
Skivka L. M.. IMMUNOMODULATORY PROPERTIES OF THE HUMAN INTESTINAL MICROBIOTA AND PROSPECTS FOR THE USE OF PROBIOTICS FOR PROPHYLAXIS AND CORRECTION OF INFLAMMATORY PROCESSES. Biotechnologia Acta 2015; 8(3): 28 doi: 10.15407/biotech8.03.028
121
M. Fukata, M.T. Abreu. TLR4 signalling in the intestine in health and disease. Biochemical Society Transactions 2007; 35(6): 1473 doi: 10.1042/BST0351473
122
Katherine Anne Siminovitch. Advances in the molecular dissection of inflammatory bowel disease. Seminars in Immunology 2006; 18(4): 244 doi: 10.1016/j.smim.2006.03.012
123
Dongjie Wang, D. Plewczynski. NOD1 and NOD2 Are Potential Therapeutic Targets for Cancer Immunotherapy. Computational Intelligence and Neuroscience 2022; 2022: 1 doi: 10.1155/2022/2271788
124
Saatheeyavaane Bhuvanendran, Hani M. Hussin, Lila P. Meran, Amy A. Anthony, Leilei Zhang, Lauranell H. Burch, Kia K. Phua, Asma Ismail, Prabha Balaram. Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and typhoid susceptibility in Asian Malay population in Malaysia. Microbes and Infection 2011; 13(10): 844 doi: 10.1016/j.micinf.2011.04.007
125
Sawsan Feki, Dorra Bouzid, Olfa Abida, Lassaad Chtourou, Nesrine Elloumi, Amina Toumi, Hend Hachicha, Ali Amouri, Nabil Tahri, Hatem Masmoudi. Genetic association and phenotypic correlation of TLR4 but not NOD2 variants with Tunisian inflammatory bowel disease. Journal of Digestive Diseases 2017; 18(11): 625 doi: 10.1111/1751-2980.12552
126
Daniel R Gaya, Richard K Russell, Elaine R Nimmo, Jack Satsangi. New genes in inflammatory bowel disease: lessons for complex diseases?. The Lancet 2006; 367(9518): 1271 doi: 10.1016/S0140-6736(06)68345-1
127
Marija Perica, Mandica Vidović, Lovro Lamot, Lana Tambić Bukovac, Sanja Kapitanović, Magdalena Perić, Jerko Barbić, Miroslav Harjaček. Single nucleotide polymorphism of toll-like receptor 4 (TLR4) is associated with juvenile spondyloarthritis in Croatian population. Clinical Rheumatology 2015; 34(12): 2079 doi: 10.1007/s10067-015-2952-8
128
Pierre-Alexandre Krayenbuehl, Martin Hersberger, Kaspar Truninger, Beat Müllhaupt, Friedrich E. Maly, Mario Bargetzi, Georg Schulthess. Toll-like receptor 4 gene polymorphism modulates phenotypic expression in patients with hereditary hemochromatosis. European Journal of Gastroenterology & Hepatology 2010; 22(7): 835 doi: 10.1097/MEG.0b013e3283322067
129
Jesús K. Yamamoto-Furusho. Genetic Susceptibility in Inflammatory Bowel Disease. Clinical Reviews in Bone and Mineral Metabolism 2010; 8(3): 149 doi: 10.1007/s12018-009-9068-0
130
S Vermeire, P Rutgeerts. Current status of genetics research in inflammatory bowel disease. Genes & Immunity 2005; 6(8): 637 doi: 10.1038/sj.gene.6364257
131
Maria Konstantinidou, Nikos Goutas, Dimitrios Vlachodimitropoulos, Antigoni Chaidaroglou, Demetrios Stefanou, Nikoleta Poumpouridou, Renata Mastorakou, Maria Gazouli, Dimitrios Kyparissopoulos, Chara Spiliopoulou. TLR-4 and CD14 Genotypes and Soluble CD14: Could They Predispose to Coronary Atherosclerosis?. Journal of Cardiovascular Development and Disease 2016; 3(1): 9 doi: 10.3390/jcdd3010009
132
Marta Kaczmarek-Ryś, Szymon Tytus Hryhorowicz, Emilia Lis, Tomasz Banasiewicz, Jacek Paszkowski, Maciej Borejsza-Wysocki, Jarosław Walkowiak, Wojciech Cichy, Piotr Krokowicz, Elżbieta Czkwianianc, Andrzej Hnatyszyn, Iwona Krela-Kaźmierczak, Agnieszka Dobrowolska, Ryszard Słomski, Andrzej Pławski. Crohn’s Disease Susceptibility and Onset Are Strongly Related to Three NOD2 Gene Haplotypes. Journal of Clinical Medicine 2021; 10(17): 3777 doi: 10.3390/jcm10173777
133
Lili Magyari, Judit Bene, Katalin Komlósi, Gábor Talián, Bernadett Faragó, Veronika Csöngei, Luca Járomi, Enikő Sáfrány, Csilla Sipeky, Lilla Lakner, Márta Varga, Beáta Gasztonyi, Béla Melegh. Prevalence of SLC22A4 1672T and SLC22A5 −207C combination defined TC haplotype in Hungarian ulcerative colitis patients. Pathology & Oncology Research 2007; 13(1): 53 doi: 10.1007/BF02893441
134
T Boraska Jelavić, M Barišić, I Drmic Hofman, V Boraska, E Vrdoljak, M Peruzović, I Hozo, Ž Puljiz, J Terzić. Microsatelite GT polymorphism in the toll‐like receptor 2 is associated with colorectal cancer. Clinical Genetics 2006; 70(2): 156 doi: 10.1111/j.1399-0004.2006.00651.x
135
Luciana Rigoli, Claudio Romano, Rosario Alberto Caruso, Maria A Lo Presti, Chiara Di Bella, Vincenzo Procopio, Giuseppina Lo Giudice, Maria Amorini, Giuseppe Costantino, Maria D Sergi, Caterina Cuppari, Giovanna Elisa Calabr&ograve;, Romina Gallizzi, Carmelo Damiano Salpietro, Walter Fries. Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease. World Journal of Gastroenterology 2008; 14(28): 4454-4461 doi: 10.3748/wjg.14.4454
136
F. Aytül Uyar, Hülya Över-Hamzaoğlu, Filiz Türe, Ahmet Gül, Nurdan Tözün, Güher Saruhan-Direskeneli. Distribution of Common CARD15 Variants in Patients with Sporadic Crohn’s Disease: Cases from Turkey. Digestive Diseases and Sciences 2006; 51(4): 706 doi: 10.1007/s10620-006-3195-y
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345